Last update 21 Nov 2024

Mitiglinide Calcium Hydrate/Voglibose

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glubes, Mitiglinide/voglibose, Voglibose/mitiglinide
+ [3]
Target
MGAM x Potassium channel x VGKCs
Mechanism
MGAM inhibitors(Maltase-glucoamylase inhibitors), Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.
Active Organization
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (22 Apr 2011),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Structure

Molecular FormulaC10H21NO7
InChIKeyFZNCGRZWXLXZSZ-CIQUZCHMSA-N
CAS Registry83480-29-9
View All Structures (2)

Related

2
Clinical Trials associated with Mitiglinide Calcium Hydrate/Voglibose
JPRN-UMIN000008332 / CompletedNot ApplicableIIT
Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function - EGEF trial
JPRN-UMIN000007203 / Completed
A clinical study of combination drug against type 2 diabetes - Glubes combination tablets for patients poorly controlled with a-GI or Glinide - - A clinical study of combination drug against type 2 diabetes - Glubes combination tablets for patients poorly controlled with a-GI or Glinide -
100 Clinical Results associated with Mitiglinide Calcium Hydrate/Voglibose
Login to view more data
100 Translational Medicine associated with Mitiglinide Calcium Hydrate/Voglibose
Login to view more data
100 Patents (Medical) associated with Mitiglinide Calcium Hydrate/Voglibose
Login to view more data
100 Deals associated with Mitiglinide Calcium Hydrate/Voglibose
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10B
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
JP
Kissei Pharmaceutical Co., Ltd.Kissei Pharmaceutical Co., Ltd.
22 Apr 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free